[
  {
    "objectID": "pharmaverse.html",
    "href": "pharmaverse.html",
    "title": "End-to-End Submissions in R with the Pharmaverse",
    "section": "",
    "text": "Code\nlibrary(admiral)\n\n\nIntroduction\nSlides\n\nInstructors\n\nDaniel Sjoberg (MSK -&gt; Roche/Genentech)\nBecca Krouse (GSK)\nBen Straub (GSK)\nRam Ganapathy (Syneos -&gt; Roche/Genentech)\n\n\n\nWhat is this workshop\n\nGet data into CDISC standards (ADaM and SDTM domains)\nPharmaverse\nAlign pharma industry on a standard process\nData collection to submission\nR packages to support Clinical Reporting in R\nCreate SDTM from raw data (CDASH and non-CDASH formats)\nCreate ADaM datasets from SDTM\nMultiple ways to create tables\n\n\n\nEnd-to-End\n\npharmaverse raw\npharmaverse SDTM\npharmaverse ADaM\n\n\n\nExercise 1\n\nCode\n# Let's warm-up!\n\nlibrary(dplyr)\nlibrary(pharmaverseadam)\n\n# Using dplyr:\n#  - From the ADSL dataset:\n#   - Subset to the safety population (SAFFL == \"Y\")\n#   - calculate the number of unique subjects in each treatment group (TRT01A)  \n\n# View(pharmaverseadam::adsl)\n\nknitr::kable(\n  pharmaverseadam::adsl |&gt; \n    dplyr::filter(SAFFL == \"Y\") |&gt; \n    dplyr::group_by(TRT01A) |&gt;\n    dplyr::summarise(n = dplyr::n_distinct(SUBJID))\n)\n\n\n\n\nTRT01A\nn\n\n\n\n\nPlacebo\n86\n\n\nXanomeline High Dose\n72\n\n\nXanomeline Low Dose\n96\n\n\n\n\n\n\nSDTM Mapping\nSlides\n\nSDTM\nStudy Data Tabulation Model\n\nMapping raw data to standards\nraw (EDC) to SDTM is difficult\nSDTM across companies is standard\nSDTM -&gt; ADaM is easy\n\n\n\nsdtm.oak package\n\nAccommodates varying raw data structures from different EDC systems and vendors\n\n\n\nAlgorithms\n\nvariables with similar mapping algorithms are grouped together\n16,000 vars can be grouped into 22 groups\nalgorithms are backbone of oak\n\nassign_no_ct() -&gt; no controlled terminology\nassign_ct() -&gt; 1:1 mapping with controlled terminology\nassign_datetime() -&gt; ISO8601 format\nhardcode_ct() -&gt; text on EDC (eg units)\n\n\nCompared to dplyr\n\ndo not have to write case_when statements\n\n\n\nTopic Variables\n\nIdentifier (ID of record)\nQualifier (what is the variable)\nTiming (when was variable collected)\n\n\n\nEDC Domains\n\n\n\nEDC Domain\nCode\n\n\n\n\nDemographics\nDM\n\n\nMedical History\nMH\n\n\nAdverse Events\nAE\n\n\nConcomitant Medications\nCM\n\n\nLaboratory Results\nLB\n\n\nVital Signs\nVS\n\n\nPhysical Examination\nPE\n\n\nStudy Drug Administration\nDA\n\n\nSubject Disposition\nDS\n\n\nEfficacy Assessments\nEF\n\n\nSafety Assessments\nSA\n\n\nQuestionnaires\nQS\n\n\nImaging Assessments\nIMG\n\n\nRandomization\nRAND\n\n\nProtocol Deviations\nPD\n\n\n\n\n\nExample Raw -&gt; SDTM mapping\nCode\n\nvs Domain example\ndm domain example\n\n\nCode\nlibrary(sdtm.oak)\nlibrary(pharmaverseraw)\nlibrary(dplyr)\n\n# AE aCRF - https://github.com/pharmaverse/pharmaverseraw/blob/main/vignettes/articles/aCRFs/AdverseEvent_aCRF.pdf\n\n# Read in Raw dataset ----\nae_raw &lt;- pharmaverseraw::ae_raw\n\n# Generate oak_id_vars ----\nae_raw &lt;- ae_raw %&gt;%\n  generate_oak_id_vars(\n    pat_var = \"PATNUM\",\n    raw_src = \"ae_raw\"\n  )\n\n# Read in Controlled Terminology\nstudy_ct &lt;-  data.frame(\n  codelist_code = c(\"C66742\", \"C66742\"),\n  term_code = c(\"C49487\", \"C49488\"),\n  term_value = c(\"N\", \"Y\"),\n  collected_value = c(\"No\", \"Yes\"),\n  term_preferred_term = c(\"No\", \"Yes\"),\n  term_synonyms = c(\"No\", \"Yes\"),\n  stringsAsFactors = FALSE\n)\n\n# Exercise 1 ------------------------------------------------\n# Map AETERM from raw_var=IT.AETERM, tgt_var=AETERM\nae &lt;-\n  # Derive topic variable\n  # Map AETERM using assign_no_ct\n  assign_no_ct(\n    raw_dat = ae_raw,\n    raw_var = \"IT.AETERM\",\n    tgt_var = \"AETERM\",\n    id_vars = oak_id_vars()\n  )\n\n# Exercise 2 ------------------------------------------------\n# Map AESER from raw_var=IT.AESER, tgt_var=AESER. Codelist code for AESDTH is C66742\nae &lt;- ae %&gt;%\n  # Map AESER using ??\n  assign_ct(\n    raw_dat = ae_raw,\n    raw_var = \"IT.AESER\",\n    tgt_var = \"AESER\",\n    ct_spec = study_ct,\n    ct_clst = \"C66742\",\n    id_vars = oak_id_vars()\n  )\n\n# Exercise 3 ------------------------------------------------\n# Map AESDTH from raw_var=IT.AESDTH, tgt_var=AESDTH. Annotation text is \n# If \"Yes\" then AESDTH = \"Y\" else Not Submitted. Codelist code for AESDTH is C66742\n\nae &lt;- ae %&gt;%\n  # Map AESDTH using condition_add & assign_ct, raw_var=IT.AESDTH, tgt_var=AESDTH\n  assign_ct(\n    raw_dat = condition_add(ae_raw, IT.AESDTH == \"Yes\"),\n    raw_var = \"IT.AESDTH\",\n    tgt_var = \"AESDTH\",\n    ct_spec = study_ct,\n    ct_clst = \"C66742\",\n    id_vars = oak_id_vars()\n  )\n\n\n\n\nADaM"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "POSIT::CONF(2025)",
    "section": "",
    "text": "We attended the Posit Conference in Atlanta, GA.\nThis is a website organizing all the topics and notes from the sessions we attended.\n\nSessions\n\n\n\nSession\nDay\nTime\nAttendee\n\n\n\n\nR/Pharma Summit\nMonday, Sept 15\n9am-5pm\nPeter & Nick\n\n\nPharmaverse for Regulatory Submissions\nTuesday, Sept 16\n9am-5pm\nPeter\n\n\nProgramming with LLM APIs\nTuesday, Sept 16\n9am-5pm\nNick\n\n\nPlaceholder\nWednesday, Sept 17\n\n\n\n\nPlaceholder\nThursday, Sept 18\n\n\n\n\n\n\n\nEvents\n\n\n\n\n\n\n\n\n\nSession\nDay\nTime\nAttendee\n\n\n\n\nrPharma meetup at SKOL Brewery\nSunday, Sept 14\n7pm\nPeter & Nick\n\n\nrPharma social event at White Oak\nMonday, Sept 15\n6pm\nPeter & Nick\n\n\nWelcome Reception\nTuesday, Sept 16\n7pm\nPeter & Nick\n\n\nGeorgia Aquarium\nWednesday, Sept 17\n7pm\nPeter & Nick"
  },
  {
    "objectID": "rPharma.html",
    "href": "rPharma.html",
    "title": "R/Pharma Summit",
    "section": "",
    "text": "About\n\nOrganizers:\n\nPhil Bowsher (Posit)\nJames Black (Roche)\nHarvey Lieberman (Novartis)\nKatie Igartua (Tempus)\n\nAttendance: 100+ people from pharma, biotech, and CRO/contractors\nLink: https://rinpharma.github.io/rinpharma-summit-2025/\nSponser: Open Source in Pharma\n\n\nREGN Attendees\n\nPeter Ehmann (PMQTS)\nNick Giangreco (PMQTS)\nRyan Yu (BDM)\nSri Pavan Vemuri (BDM)\n\n\n\nAtorus\n\nSteve Nicholas\nAshley Tarasiewicz\n\n\n\n\nROI in Open Source\n\nWhy use open-source?\n\ncollaboration, faster innovation\nnot just R, but python\nopens up talent pool\nnot spending time training to learn SAS\nwhat are students coding in grad school\n\n\n\nWhat is the ROI?\n\ndifficult to measure\nprove it with POC\ntipping point (financial cost)\n\npropriety vs.\nopen-source\n\nexperiment SAS vs. R timing to program SDTM tables\n\nautomation\ncustomization\nfinal product\n\nnot just cost, but mindset shift\nPMQTS - analagous to shift from siloed coding to best practices\n\nsavings are not apparent up-front\nROI is difficult to calculate and communicate\nPOC and reach tipping point\n\n\n\n\nWho do we need to influence?\n\nhealth authorities\nbusiness IT\n\n\n\nWhat to demystify?\n\nvalidation\nreproducibility\nopen-source\n\n\n\n\nQuality in Open-Source\n\nLinks\n\nhttps://rpodcast.quarto.pub/quality-rphsummit2025/#/titleslide\nhttps://rstats.wtf/\n\n\n\nWhat is quality\nQuality Assurance (QA) and Quality Control (QC) are two distinct but interconnected components crucial to ensuring pharmaceutical products’ safety, efficacy, and reliability. QA and QC in the pharmaceutical industry collectively form a comprehensive framework for maintaining high-quality standards throughout pharmaceutical manufacturing.\n\n\nBenefits of open-source\n\nTFL generation\nMulti use tools: shiny, packages (don’t have to start from skratch)\nData repository\n\n\n\nWhy open-source\n\nUser facing vs. Quality facing documentation (know your audience)\nUser -&gt; see underlying code and flag issues\nQuality -&gt; should know author(s) and tests performed (maintenance strategy)\nMaintenance\n\nproject re-assinged\nemployee leaves (turnover)\nphase out\nGIT!!! - learning curve is steep (barrier to entry)\n\ndevelopment\ntransparency\nbranching - try things and not break\n\nstandardization vs. harmonization !!!\nconsider yourself as a collaborator\nintangible\n\ninvestment\neliminating resistance to change\nembrace new approaches\nspeak the same language (get on the same level) - use non-technical terms\n“thats how it worked before” is not a reason (ex Gen AI)\nrigid vs flexible mindset\n\n\n\n\n\n\nGenAI and Clinical Trials\n\nGilead\nEli Lilly\n\n\nLLMs\n\nLLM is an instruction following engine with no memory\nProvide:\n\nprecise instructions\nsupply the right information at the right time\n\nTool Calls\nModel, Context, Protocol (MCP)\nevals are critical for testing and development\nwe can’t test everything, and LLMs will screw up\n\nadopt version control (oversight)\n\ncreate ways to find errors\nCurrent state: do not make plans before piloting\n\nplay with current tools\ndo not plan to put things in production in 2025\nfigure out what it is good at, vs not good at\n\nUse cases:\n\nmostly documentation\nnobody mentioned as junior analyst (@Natalie)\n\nBuild foundation to be ready when the models improve\nIs it doing what it’s meant to do?\n\nGive it to high performers\nIf it fails, it will get shut down early.\n\n\n\n\nComprehensive C-QT Analysis From Data to Deliverables\nhttps://a2-ai.github.io/cqtkit-docs/versions/1.0.2/\n\n\n\nGenAI in Positron\n\nPolyglot IDE - R, Python, SQL, Rust, Julia,\nFork of VS Code\nClaude integration into Positron\n\nknows all environment variables\n\n\n\n\nValidation Hub\n\nR consortium project\n10 organizations\nInvolvement from health authorities\n\n\n\nRoundtable 1 - Perspectives of CROs\n\nDenali\nCytel\nAtorus\nSyneos\n\nTakeaway: Need to have time for learning & leveling up to enable open-source adoption.\n\n\nRoundtable 2 - Open-Source Change Manangement\n\nGSK\nGenentech/Roche\n\nTakeaway: Trainings are ineffective, need to implement best practices in everyday work.\n\nGSK uses “just in time training”\nAdvanced programmer is teamed with novice programmer to implement best practices in a real-world setting\nCoders will only adopt change if they have to"
  }
]